In the U.S. Substance abuse has become a major cause of concern. People in this country are increasingly getting addicted to a variety of drugs, affecting their health and their family life to a large extent.
- Advertising -
U.S. Substance Abuse Treatment Market: Snapshot
With prolonged drug and alcohol abuse, the prevalence of mental illness and various chronic diseases, such as diabetes and cardiovascular disorders, have increased substantially among consumers, creating a high economic burden on the nation. To control this situation, the U.S.
government is focusing on adopting the early intervention as well as prevention strategies, which is expected to drive significant demand for substance abuse treatments, reflecting impressively on the U.S. substance abuse treatment market.
View Report @ www.transparencymarketresearch.com…tment-market.html
Currently, all medications used in the treatments of people struggling with substance abuse have been thoroughly examined by the FDA and found to be highly efficient when used properly, under the direction of the prescribing physician. The market is also anticipated to gain remarkably from this in the near future.
- Advertising -
Drug Abuse Treatment Dominates U.S. Substance Abuse Treatment Market
Alcohol dependence, tobacco/nicotine addiction, and opioid addiction are the main types of substance addiction, a number of U.S. citizens have fallen prey to. With around 15% of the overall population in the U.S.
addicted to smoking, the tobacco/nicotine addiction takes the lead among the types of substance abuse taking place in the U.S.
The key treatments for substance abuse, applied in the U.S., are alcohol addiction treatment, tobacco or Nicotine addiction treatment and drug abuse treatment. Drug abuse treatment reports a higher demand from end users than other substance abuse treatments.
Analysts expect this scenario to remain same over the next few years. Methadone, buprenorphine, and naltrexone are the main types of drug abuse treatments utilized in this country.
Product innovation in buprenorphine pills and film, and the recent launch of buprenorphine implants is likely to boost the drug abuse treatment segment remarkably in the near future.
Get accurate market forecast and analysis on the Medical Image Analysis Software Market. Request a sample to stay abreast on the key trends impacting this market.
Disulfiram, acamprosate, and naltrexone are the most widely preferred drugs for the treatment of patients struggling with alcohol addiction. Acamprosate is expected to account for the most prominent share among these drugs over the forthcoming years.
Nicotine replacement treatment and non-nicotine medications have emerged as the most effective treatments for tobacco or nicotine addiction.
Thanks to Increasing Popularity of Outpatient Rehab, Outpatient Treatment Centers to Remain Lead among End Users
Outpatient treatment centers, residential treatment centers, and inpatient treatment centers have surfaced as the key end users of the substance abuse treatment in the U.S. Among these, the demand for these treatments is higher in outpatient treatment centers and is anticipated to remain so over the coming years, thanks to the rising popularity of outpatient rehab across the country.
The U.S. substance abuse treatment market is highly fragmented with a large number of companies operating in it. The prominent ones in them are Mallinckrodt, Purdue Pharma L.P., Sanofi, Dr.
Reddy’s Laboratories Ltd., Pfizer Inc., GlaxoSmithKline Plc, Cipla Ltd., Allergan Plc, and Alkermes.
Category: Market Research Publishers and RetailersCompany profile: TMR provides a range of marketing and business research solutions designed for your specific needs. From off-the-shelf syndicated business And market research to made-to-order custom research, we serve our clients to fulfill their immediate as well as ongoing research requirements. We specialize in the following areas: Syndicated Research Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemical, energy, food & beverage ...
For more information: